tirzepatide anemia Does (a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist) increase hematocrit levels in a patient with human immunodeficiency virus (HIV)-associated lipodystrophy and a history of Anaemia on Ozempic, Mounjaro or

Methods This retrospective cross-sectional study included patients who underwent assessments of solid gastric emptying time (GET) by technetium-99m scintigraphy between May 2019 and December 2020

The expansion of GLP-1 drug efficacy evidence in 2024, a concise review by Daniel Drucker, a pioneer of the field | 28 comments on LinkedIn

PlexusDx offers compounded tirzepatide as a more accessible alternative starting at $249 per month

Eli Lilly's new pill starts shipping today, Novo Nordisk's oral Wegovy is three months into its launch, and doctors are already telling us that the way patients think about these drugs is shifting fast.

A large Cleveland Clinic study has found that people with obesity and Type 2 diabetes who undergo weight-loss surgery live longer and face fewer serious health problems compared with those treated with GLP-1 receptor agonist medicines alone.